Vascular Access Device Market

7500+ companies worldwide approach us every year for their revenue growth initiatives
Global top 2000 strategist rely on us for their growth strategies.
80% of fortune 2000 companies rely on our research to identify new revenue sources.
30000 High Growth Opportunities
95% renewal rate
KNOW MORE
  1. HOME
  2. Top Market Reports
  3. Vascular Access Device Market

Vascular Access Device Market by Type (Central (Peripheral, Tunneled, Non- tunneled, Implanted Ports), Peripheral (Short, Midline, Winged)), Application (Drug, Blood, Fluid, Diagnostic), End User (Hospitals, Clinics, Ambulatory) & Region - Global Forecast to 2028

FREE BROCHURE FREE SAMPLE REPORT
Report Code: MD 5434 Jul, 2023, by marketsandmarkets.com

The global vascular access device market in terms of revenue was estimated to be worth $5.6 billion in 2023 and is poised to reach $7.9 billion by 2028, growing at a CAGR of 7.0% from 2023 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.

Growth in this market is majorly driven by significant government investments in cutting-edge medical devices, and rising prevalence of lifestyle diseases.However, shortage of skilled professionals are expected to challenge market growth to a certain extent.

Global Vascular Access Device Market Trends

Vascular Access Device Market

To know about the assumptions considered for the study, Request for Free Sample Report

Vascular Access Device Market

Vascular Access Device Market Dynamics

Driver: Growing prevalence of lifestyle diseases

According to the World Health Organization 2021, Cardiovascular diseases (CVDs) are the leading cause of death globally. An projected 17.9 million people died from CVDs in 2019, representing 32 percent of all global deaths. Of these deaths, 85 percent were due to heart attack and stroke. For instance, according to World Heart Federation vision 2030, the number of CVD deaths is projected to rise from an estimated 18,9 million in 2020 to over 22,2 million in 2030 and 32,3 million in 2050.With the growing prevalence of diabetes, the number of patients suffering from chronic kidney disease is also expected to increase in the coming years, as diabetes is a major risk factor for CKD. The growing prevalence of these health conditions, particularly CKD and CVDs, is expected to support the growth of the vascular access device market as tunneled and non-tunneled catheter devices are widely used in dialysis procedures and the treatment of various cardiovascular diseases.

Restraint: High costs involved in the placement and maintenance of vascular access device

Vascular access device are relatively costly devices and the price of the product changes with the type of vascular access device (VADs) used in a procedure. The average cost of a vascular access device varies from USD 150 to USD 900. Moreover, the physician price associated with the insertion of VADs varies from USD 20 to USD 90 per hour. The price of vascular access procedures rises in case of patient hospitalization, and complications such as central catheter bloodstream infections or occlusions can drastically rise the cost of the procedure. According to the Canadian Association of Nurses in Oncology, in the US, a central catheter bloodstream infection can shoot up procedure price to more than USD 25,000. These high placement and maintenance price for vascular access device (VADs) are expected to restrain market growth during the forecast period.

Opportunity: Technological advancements

Ultrasound is a broadly available, non-invasive technique and is thus the most broadly used vessel visualization method. As a cost-effective method, it allows the evaluation of vascular access maturity and diagnosis of complications; in the recent years, image-guided vascular access has emerged as a new, efficient method offering precise results. The use of ultrasound imaging during VAD insertion has become more common. It helps healthcare professionals visualize the veins in real-time, increasing the success rate of first-attempt insertions and reducing complications like accidental arterial punctures and hematoma formation.

Challenge: Shortage of skilled professionals

Skilled professionals are involved to handle vascular access device as their improper insertion may cause medical complications in patients. Complications like damage to blood vessels, bleeding at the site, entrance of air into the vein (air embolus), injury to the lung (pneumothorax), and bloodstream infections can happen during the usage of VADs. According to a survey on the latest business conditions conducted by the National Association for Business Economics (NABE), 35% of participants reported that there is a shortage of skilled professionals in the US. This shortage of skilled professionals in major markets across the globe is expected to affect the demand and uptake of VADs during the forecast period.

Vascular Access Device Market Ecosystem Map

Vascular Access Device Market Ecosystem

By type, the central vascular access device segment is accounted for the largest share of the vascular access device industry during the forecast period

Based on type, within the vascular access device market, there are peripheral access device, central vascular access device, and accessories holding a significant portion. The central vascular access device segment is hold  the largest share of the global vascular access device market. This predominance is attributed to the wide usage of central vascular access device in chemotherapy and in the treatment of cardiovascular disorders and chronic kidney disorders.

The drug administration accounted for the largest share of the vascular access device industry during the forecast period, by application

Based on applications, vascular access device market is divided into segments including drug administration, fluid and nutrition administration,blood transfusion, and diagnostic & testing. The significant share of the drug administration segment can be attributed to various factors. These factors include  high usage of vascular access device for drug administration, particularly for the treatment of infections and cancer.

The hospitals segment accounted for the largest share of the vascular access device industry in 2022, by end user

Based on end users, the global vascular access device market categorized into hospitals, clinics & ambulatory centers, and other end users (nursing homes, laboratories, diagnostic & imaging centers, and home healthcare agencies). The dominance of this segment can be attributed to several significant factors. These factors include majority of vascular procedures are performed in hospital settings. Also, emergency care in hospitals requires VADs for blood transfusion and administration of various drugs.

North America to witness significant growth in the vascular access device industry from 2023 to 2028

On the basis of region, the global vascular access device market is segmented into-North America, Europe, Asia Pacific, and Rest of the World.In 2023, North America projected to lead market share of the vascular access device market. This can be attributed to the region benefits from the presence of key players, a supportive reimbursement framework, and significant government investments in cutting-edge medical devices.

Vascular Access Device Market by Region

To know about the assumptions considered for the study, download the pdf brochure

The prominent players in this market are Becton, Dickinson and Company (US), ICU Medical, Inc. (US), Teleflex Incorporated (US), B. Braun SE (Germany), AngioDynamics, Inc. (US), Terumo Corporation (Japan), Nipro Medical Corporation (Japan), Medtronic (Ireland), Amecath (Egypt),Romsons (India), PRODIMED (France),Cook Medical (US), Access Vascular, Inc. (US), Medical Components, Inc. (US), Vygon (France), 3M (US), Argon Medical Devices (US), Guangdong Baihe Medical Technology Co., Ltd. (China), pfm medical (Germany), Medi-Tech Devices Pvt Ltd (India), Medline Industries, LP (US), Kimal (UK), Deltamed (Italy), Newtech Medical Devices (India) and Shanghai Puyi Medical Instruments Co., Ltd (China).

Scope of the Vascular Access Device Industry

Report Metric 

Details 

Market Revenue in 2023

$5.6 billion

Projected Revenue by 2028

$7.9 billion

Revenue Rate

Poised to Grow at a CAGR of 7.0%

Market Driver

Growing prevalence of lifestyle diseases

Market Opportunity

Technological advancements

The study categories the vascular access device market to forecast revenue and analyze trends in each of the following submarkets:

By Type

  • Central vascular access device
  • Tunneled catheters
  •  Non-tunneled catheters
  •  Implanted ports
  • Peripherally inserted central catheters
  • Peripheral vascular access device
  • Peripheral midlines devices
  • Peripheral short devices
  • Butterfly/winged steel needles
  • Accessories

By Application

  • Drug administration
  • Fluid and nutrition administration
  • Blood transfusion
  • Diagnostics and testing

By End User

  • Hospital
  • Clinics and ambulatory care centers
  • Other end users (home healthcare agencies, nursing homes, and diagnostic & imaging centers)

By Region

  • North America
    • US
    • Canada
  • Europe
    • France
    • Spain
    • UK
    • Italy
    • Germany
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Rest of APAC
  • Rest of the World

Recent Developments of Vascular Access Device Industry

  • In June 2023, Teleflex Incorporated (US) has been awarded two group purchasing agreements with Premier, Inc. The new agreements allow Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for Teleflex’s Central Venous and Arterial Vascular Access products.
  • In June 2022, Teleflex Incorporated (US) launched an Arrow Pressure Injectable Midline Catheter in Australia and New Zealand. The addition of the pressure injectable catheter further enhances the Midline portfolio to meet the expanded needs of clinicians and is designed to improve patient safety.
  • In January 2022, ICU Medical, Inc. (US) completed its acquisition of Smiths Medical (US) from Smiths Group plc. The Smiths Medical business includes syringe and ambulatory infusion devices, vascular access, and vital care products. When combined with ICU Medical’s existing businesses, the combined companies establish a leading infusion therapy company with estimated pro forma combined revenues of approximately USD 2.5 billion.
  • In July 2021, Becton, Dickinson and Company (US) acquired Velano Vascular (US). Velano Vascular needle-free technology enables high-quality blood draws from existing peripheral intravenous catheter (PIVC) lines. This acquisition can now enable health care providers to help eliminate multiple needlesticks for blood sample collection, reducing the pain and discomfort from the process while delivering quality outcomes and increased patient satisfaction.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION (Page No. - 25)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION 
           1.2.1 INCLUSIONS & EXCLUSIONS
           1.2.2 MARKETS COVERED
                    FIGURE 1 VASCULAR ACCESS DEVICES MARKET SEGMENTATION
           1.2.3 REGIONAL SEGMENTATION
           1.2.4 YEARS CONSIDERED
    1.3 CURRENCY 
    1.4 STAKEHOLDERS 
    1.5 SUMMARY OF CHANGES 
 
2 RESEARCH METHODOLOGY (Page No. - 29)
    2.1 RESEARCH DATA 
          FIGURE 2 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
                    2.1.1.1 Key data from secondary sources
           2.1.2 PRIMARY DATA
                    FIGURE 3 PRIMARY SOURCES
                    2.1.2.1 Key data from primary sources
                    2.1.2.2 Key industry insights
                                FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE PARTICIPANTS
    2.2 MARKET SIZE ESTIMATION 
          FIGURE 5 MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS
          FIGURE 6 REVENUE SHARE ANALYSIS ILLUSTRATION: BECTON, DICKINSON AND COMPANY
          FIGURE 7 SEGMENTAL EXTRAPOLATION: GLOBAL VASCULAR ACCESS DEVICES MARKET (2022)
          FIGURE 8 BOTTOM-UP APPROACH: GLOBAL VASCULAR ACCESS DEVICES MARKET (2022)
          FIGURE 9 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
          FIGURE 10 CAGR PROJECTIONS
          FIGURE 11 TOP-DOWN APPROACH
    2.3 MARKET BREAKDOWN & DATA TRIANGULATION 
          FIGURE 12 DATA TRIANGULATION METHODOLOGY
    2.4 STUDY ASSUMPTIONS 
    2.5 LIMITATIONS 
           2.5.1 METHODOLOGY-RELATED LIMITATIONS
    2.6 RISK ASSESSMENT 
    2.7 VASCULAR ACCESS DEVICES MARKET: RECESSION IMPACT 
 
3 EXECUTIVE SUMMARY (Page No. - 43)
    FIGURE 13 VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)
    FIGURE 14 VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2023 VS. 2028  (USD MILLION)
    FIGURE 15 VASCULAR ACCESS DEVICES MARKET, BY END USER, 2023 VS. 2028  (USD MILLION)
    FIGURE 16 GEOGRAPHICAL SNAPSHOT OF VASCULAR ACCESS DEVICES MARKET
 
4 PREMIUM INSIGHTS (Page No. - 46)
    4.1 VASCULAR ACCESS DEVICES MARKET OVERVIEW 
          FIGURE 17 GROWING PREVALENCE OF LIFESTYLE DISEASES TO DRIVE MARKET GROWTH
    4.2 ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET,  BY END USER 
          FIGURE 18 HOSPITALS ACCOUNTED FOR LARGEST SHARE OF APAC MARKET IN 2022
    4.3 VASCULAR ACCESS DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 
          FIGURE 19 CHINA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
    4.4 REGIONAL MIX: VASCULAR ACCESS DEVICES MARKET  (2021–2028) 
          FIGURE 20 ASIA PACIFIC MARKET TO GROW AT HIGHEST RATE DURING FORECAST PERIOD
    4.5 VASCULAR ACCESS DEVICES MARKET: DEVELOPED VS. EMERGING ECONOMIES 
          FIGURE 21 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
 
5 MARKET OVERVIEW (Page No. - 50)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
          FIGURE 22 VASCULAR ACCESS DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,  AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Growing prevalence of lifestyle diseases
                    5.2.1.2 Increasing number of chemotherapy procedures
                    5.2.1.3 Growing use of vascular access devices in pediatric patients
           5.2.2 RESTRAINTS
                    5.2.2.1 High cost associated with placement and maintenance of vascular access devices
                    5.2.2.2 Product recalls and failures
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Technological advancements
                    5.2.3.2 Growth in number of hospitals
           5.2.4 CHALLENGES
                    5.2.4.1 Shortage of skilled professionals
                    5.2.4.2 Risks associated with vascular access devices
    5.3 INDUSTRY TRENDS 
           5.3.1 MINIMALLY INVASIVE VASCULAR ACCESS PROCEDURES
           5.3.2 INNOVATIONS IN CATHETER MATERIALS AND COATINGS
    5.4 VALUE CHAIN ANALYSIS 
          FIGURE 23 MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES
    5.5 ECOSYSTEM MAPPING 
           5.5.1 ROLE IN ECOSYSTEM
    5.6 PORTER’S FIVE FORCES ANALYSIS 
           5.6.1 THREAT OF NEW ENTRANTS
           5.6.2 INTENSITY OF COMPETITIVE RIVALRY
           5.6.3 BARGAINING POWER OF BUYERS
           5.6.4 BARGAINING POWER OF SUPPLIERS
           5.6.5 THREAT OF SUBSTITUTES
 
6 VASCULAR ACCESS DEVICES MARKET, BY TYPE (Page No. - 59)
    6.1 INTRODUCTION 
          TABLE 1 VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
    6.2 CENTRAL VASCULAR ACCESS DEVICES 
          TABLE 2 CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 3 CENTRAL VASCULAR ACCESS DEVICES MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
           6.2.1 PERIPHERALLY INSERTED CENTRAL CATHETERS
                    6.2.1.1 Complications associated with PICCs to limit adoption in coming years
                                TABLE 4 PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
           6.2.2 TUNNELED CATHETERS
                    6.2.2.1 Advantages of tunneled catheters such as lower risk of infection and lower chances of accidental removal to boost demand
                                TABLE 5 TUNNELED CATHETERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.2.3 NON-TUNNELED CATHETERS
                    6.2.3.1 High risk of infection to limit market growth
                                TABLE 6 NON-TUNNELED CATHETERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.2.4 IMPLANTED PORTS
                    6.2.4.1 Lowest risk of infection associated with implanted ports to support growth
                                TABLE 7 IMPLANTED PORTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
    6.3 PERIPHERAL VASCULAR ACCESS DEVICES 
          TABLE 8 PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 9 PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
           6.3.1 PERIPHERAL SHORT DEVICES
                    6.3.1.1 Ability of peripheral short devices to only administer select types of medication to hamper growth
                                TABLE 10 PERIPHERAL SHORT DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.3.2 PERIPHERAL MIDLINE DEVICES
                    6.3.2.1 Need for trained nurses for procedures to restrict growth
                                TABLE 11 PERIPHERAL MIDLINE DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.3.3 BUTTERFLY/WINGED STEEL NEEDLES
                    6.3.3.1 Wide usage of winged steel needles in blood sampling and diagnosis to propel growth
                                TABLE 12 BUTTERFLY/WINGED STEEL NEEDLES MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
    6.4 ACCESSORIES 
           6.4.1 RECURRENT NEED FOR ACCESSORIES TO BOOST MARKET
                    TABLE 13 VASCULAR ACCESS DEVICE ACCESSORIES MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
 
7 VASCULAR ACCESS DEVICES MARKET, BY APPLICATION (Page No. - 72)
    7.1 INTRODUCTION 
          TABLE 14 VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
    7.2 DRUG ADMINISTRATION 
           7.2.1 HIGH USAGE OF VASCULAR ACCESS DEVICES FOR DRUG ADMINISTRATION TO BOOST SEGMENTAL GROWTH
                    TABLE 15 VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION APPLICATIONS,  BY COUNTRY, 2021–2028 (USD MILLION)
    7.3 FLUID & NUTRITION ADMINISTRATION 
           7.3.1 GROWING USE OF PERIPHERAL VASCULAR ACCESS DEVICES FOR SHORT-TERM NUTRITIONAL THERAPY TO SUPPORT MARKET
                    TABLE 16 VASCULAR ACCESS DEVICES MARKET FOR FLUID & NUTRITION ADMINISTRATION APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
    7.4 BLOOD TRANSFUSION 
           7.4.1 FREQUENT NEED FOR BLOOD TRANSFUSION IN TREATMENT OF VARIOUS CONDITIONS TO BOOST GROWTH
                    TABLE 17 VASCULAR ACCESS DEVICES MARKET FOR BLOOD TRANSFUSION APPLICATIONS,  BY COUNTRY, 2021–2028 (USD MILLION)
    7.5 DIAGNOSTICS & TESTING 
           7.5.1 GROWING POPULARITY OF PERIPHERAL LINES FOR DIAGNOSTIC & TESTING APPLICATIONS TO DRIVE MARKET GROWTH
                    TABLE 18 VASCULAR ACCESS DEVICES MARKET FOR DIAGNOSTICS & TESTING APPLICATIONS,  BY COUNTRY, 2021–2028 (USD MILLION)
 
8 VASCULAR ACCESS DEVICES MARKET, BY END USER (Page No. - 78)
    8.1 INTRODUCTION 
          TABLE 19 VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
    8.2 HOSPITALS 
           8.2.1 HIGH DEMAND FOR VASCULAR ACCESS DEVICES IN HOSPITAL SETTINGS TO BOOST MARKET
                    TABLE 20 VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY COUNTRY,  2021–2028 (USD MILLION)
    8.3 CLINICS & AMBULATORY CARE CENTERS 
           8.3.1 GROWING PREFERENCE FOR MINIMALLY INVASIVE PROCEDURES TO SUPPORT MARKET GROWTH
                    TABLE 21 VASCULAR ACCESS DEVICES MARKET FOR CLINICS & AMBULATORY CARE CENTERS,  BY COUNTRY, 2021–2028 (USD MILLION)
    8.4 OTHER END USERS 
          TABLE 22 VASCULAR ACCESS DEVICES MARKET FOR OTHER END USERS, BY COUNTRY,  2021–2028 (USD MILLION)
 
9 VASCULAR ACCESS DEVICES MARKET, BY REGION (Page No. - 83)
    9.1 INTRODUCTION 
          TABLE 23 VASCULAR ACCESS DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
    9.2 NORTH AMERICA 
           9.2.1 NORTH AMERICA: RECESSION IMPACT
                    FIGURE 24 NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET SNAPSHOT
                    TABLE 24 NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
                    TABLE 25 NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                    TABLE 26 NORTH AMERICA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                    TABLE 27 NORTH AMERICA: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                    TABLE 28 NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION,  2021–2028 (USD MILLION)
                    TABLE 29 NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY END USER,  2021–2028 (USD MILLION)
           9.2.2 US
                    9.2.2.1 High prevalence of chronic diseases to drive market growth
                                TABLE 30 INDICATIVE LIST OF CLINICAL TRIALS CONDUCTED
                                TABLE 31 US: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 32 US: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                TABLE 33 US: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                TABLE 34 US: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                TABLE 35 US: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
           9.2.3 CANADA
                    9.2.3.1 Increasing number of minimally invasive procedures to support market growth
                                TABLE 36 CANADA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 37 CANADA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                TABLE 38 CANADA: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                TABLE 39 CANADA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION,  2021–2028 (USD MILLION)
                                TABLE 40 CANADA: VASCULAR ACCESS DEVICES MARKET, BY END USER,  2021–2028 (USD MILLION)
    9.3 EUROPE 
           9.3.1 EUROPE: RECESSION IMPACT
                    TABLE 41 EUROPE: VASCULAR ACCESS DEVICES MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
                    TABLE 42 EUROPE: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 43 EUROPE: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                    TABLE 44 EUROPE: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                    TABLE 45 EUROPE: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION,  2021–2028 (USD MILLION)
                    TABLE 46 EUROPE: VASCULAR ACCESS DEVICES MARKET, BY END USER,  2021–2028 (USD MILLION)
           9.3.2 GERMANY
                    9.3.2.1 Growing geriatric and obese populations to contribute to market growth
                                TABLE 47 GERMANY: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 48 GERMANY: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                TABLE 49 GERMANY: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                TABLE 50 GERMANY: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION,  2021–2028 (USD MILLION)
                                TABLE 51 GERMANY: VASCULAR ACCESS DEVICES MARKET, BY END USER,  2021–2028 (USD MILLION)
           9.3.3 UK
                    9.3.3.1 Increasing incidence of coronary heart disease to support market growth
                                TABLE 52 UK: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 53 UK: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                TABLE 54 UK: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                TABLE 55 UK: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                TABLE 56 UK: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
           9.3.4 FRANCE
                    9.3.4.1 Strong government support and favorable strategies & initiatives to drive market growth
                                TABLE 57 FRANCE: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 58 FRANCE: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                TABLE 59 FRANCE: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                TABLE 60 FRANCE: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION,  2021–2028 (USD MILLION)
                                TABLE 61 FRANCE: VASCULAR ACCESS DEVICES MARKET, BY END USER,  2021–2028 (USD MILLION)
           9.3.5 ITALY
                    9.3.5.1 Strong healthcare policies by government to propel growth
                                TABLE 62 ITALY: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 63 ITALY: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                TABLE 64 ITALY: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                TABLE 65 ITALY: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION,  2021–2028 (USD MILLION)
                                TABLE 66 ITALY: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
           9.3.6 SPAIN
                    9.3.6.1 Growing geriatric population to increase demand for vascular access devices
                                TABLE 67 SPAIN: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 68 SPAIN: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                TABLE 69 SPAIN: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                TABLE 70 SPAIN: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION,  2021–2028 (USD MILLION)
                                TABLE 71 SPAIN: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
           9.3.7 REST OF EUROPE
                    TABLE 72 REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                    TABLE 73 REST OF EUROPE: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                    TABLE 74 REST OF EUROPE: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                    TABLE 75 REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION,  2021–2028 (USD MILLION)
                    TABLE 76 REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET, BY END USER,  2021–2028 (USD MILLION)
    9.4 ASIA PACIFIC 
           9.4.1 ASIA PACIFIC: RECESSION IMPACT
                    FIGURE 25 ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET SNAPSHOT
                    TABLE 77 ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
                    TABLE 78 ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                    TABLE 79 ASIA PACIFIC: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                    TABLE 80 ASIA PACIFIC: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                    TABLE 81 ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION,  2021–2028 (USD MILLION)
                    TABLE 82 ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY END USER,  2021–2028 (USD MILLION)
           9.4.2 JAPAN
                    9.4.2.1 Large geriatric population to support market growth
                                TABLE 83 JAPAN: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 84 JAPAN: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                TABLE 85 JAPAN: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                TABLE 86 JAPAN: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION,  2021–2028 (USD MILLION)
                                TABLE 87 JAPAN: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
           9.4.3 CHINA
                    9.4.3.1 Growing target patient population to drive market growth
                                TABLE 88 CHINA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 89 CHINA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                TABLE 90 CHINA: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                TABLE 91 CHINA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION,  2021–2028 (USD MILLION)
                                TABLE 92 CHINA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
           9.4.4 INDIA
                    9.4.4.1 Increasing prevalence of diabetes to drive adoption of vascular access devices
                                TABLE 93 INDIA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 94 INDIA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                TABLE 95 INDIA: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                TABLE 96 INDIA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION,  2021–2028 (USD MILLION)
                                TABLE 97 INDIA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
           9.4.5 REST OF ASIA PACIFIC
                    TABLE 98 REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                    TABLE 99 REST OF ASIA PACIFIC: PERIPHERAL VASCULAR ACCESS DEVICES MARKET,  BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 100 REST OF ASIA PACIFIC: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                    TABLE 101 REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION,  2021–2028 (USD MILLION)
                    TABLE 102 REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY END USER,  2021–2028 (USD MILLION)
    9.5 REST OF THE WORLD 
           9.5.1 REST OF THE WORLD: RECESSION IMPACT
                    TABLE 103 REST OF THE WORLD: VASCULAR ACCESS DEVICES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                    TABLE 104 REST OF THE WORLD: PERIPHERAL VASCULAR ACCESS DEVICES MARKET,  BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 105 REST OF THE WORLD: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                    TABLE 106 REST OF THE WORLD: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION,  2021–2028 (USD MILLION)
                    TABLE 107 REST OF THE WORLD: VASCULAR ACCESS DEVICES MARKET, BY END USER,  2021–2028 (USD MILLION)
 
10 COMPETITIVE LANDSCAPE (Page No. - 127)
     10.1 OVERVIEW 
     10.2 STRATEGIES ADOPTED BY KEY PLAYERS 
             TABLE 108 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS
     10.3 REVENUE SHARE ANALYSIS 
             FIGURE 26 REVENUE ANALYSIS OF KEY PLAYERS IN VASCULAR ACCESS DEVICES MARKET (2020–2022)
     10.4 MARKET SHARE ANALYSIS 
             FIGURE 27 MARKET SHARE ANALYSIS OF KEY PLAYERS IN VASCULAR ACCESS DEVICES MARKET (2022)
     10.5 MARKET RANKING ANALYSIS 
             FIGURE 28 VASCULAR ACCESS DEVICES MARKET: KEY PLAYER RANKING, 2022
     10.6 COMPANY EVALUATION MATRIX 
             10.6.1 STARS
             10.6.2 EMERGING LEADERS
             10.6.3 PERVASIVE PLAYERS
             10.6.4 PARTICIPANTS
                        FIGURE 29 VASCULAR ACCESS DEVICES MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS (2022)
     10.7 COMPANY EVALUATION MATRIX FOR SMES/START-UPS 
             10.7.1 PROGRESSIVE COMPANIES
             10.7.2 DYNAMIC COMPANIES
             10.7.3 STARTING BLOCKS
             10.7.4 RESPONSIVE COMPANIES
                        FIGURE 30 VASCULAR ACCESS DEVICES MARKET: COMPANY EVALUATION MATRIX FOR SMES/START-UPS (2022)
     10.8 COMPANY FOOTPRINT ANALYSIS 
             TABLE 109 COMPANY FOOTPRINT: VASCULAR ACCESS DEVICES MARKET (2022)
             10.8.1 COMPANY FOOTPRINT, BY TYPE
                        TABLE 110 TYPE FOOTPRINT: VASCULAR ACCESS DEVICES MARKET (2022)
             10.8.2 COMPANY FOOTPRINT, BY REGION
                        TABLE 111 REGIONAL FOOTPRINT: VASCULAR ACCESS DEVICES MARKET (2022)
     10.9 COMPETITIVE SCENARIO 
             10.9.1 PRODUCT LAUNCHES
                        TABLE 112 PRODUCT LAUNCHES, JANUARY 2019–JULY 2023
             10.9.2 DEALS
                        TABLE 113 DEALS, JANUARY 2019–JULY 2023
             10.9.3 OTHER DEVELOPMENTS
                        TABLE 114 OTHER DEVELOPMENTS, JANUARY 2019–JULY 2023
 
11 COMPANY PROFILES (Page No. - 143)
(Business Overview, Products Offered, Recent Developments, MnM View Right to win, Strategic choices made, Weaknesses and competitive threats) *
     11.1 KEY PLAYERS 
             11.1.1 BECTON, DICKINSON AND COMPANY
                        TABLE 115 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
                        FIGURE 31 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022)
             11.1.2 TELEFLEX INCORPORATED
                        TABLE 116 TELEFLEX INCORPORATED: BUSINESS OVERVIEW
                        FIGURE 32 TELEFLEX INCORPORATED: COMPANY SNAPSHOT (2022)
             11.1.3 ICU MEDICAL, INC.
                        TABLE 117 ICU MEDICAL, INC.: BUSINESS OVERVIEW
                        FIGURE 33 ICU MEDICAL, INC.: COMPANY SNAPSHOT (2022)
             11.1.4 B. BRAUN SE
                        TABLE 118 B. BRAUN SE: BUSINESS OVERVIEW
                        FIGURE 34 B. BRAUN SE: COMPANY SNAPSHOT (2022)
             11.1.5 ANGIODYNAMICS, INC.
                        TABLE 119 ANGIODYNAMICS, INC.: BUSINESS OVERVIEW
                        FIGURE 35 ANGIODYNAMICS, INC.: COMPANY SNAPSHOT (2022)
             11.1.6 TERUMO CORPORATION
                        TABLE 120 TERUMO CORPORATION: BUSINESS OVERVIEW
                        FIGURE 36 TERUMO CORPORATION: COMPANY SNAPSHOT (2023)
             11.1.7 NIPRO MEDICAL CORPORATION
                        TABLE 121 NIPRO MEDICAL CORPORATION: BUSINESS OVERVIEW
                        FIGURE 37 NIPRO MEDICAL CORPORATION: COMPANY SNAPSHOT (2022)
             11.1.8 MEDTRONIC
                        TABLE 122 MEDTRONIC: BUSINESS OVERVIEW
                        FIGURE 38 MEDTRONIC: COMPANY SNAPSHOT (2022)
             11.1.9 AMECATH
                        TABLE 123 AMECATH: BUSINESS OVERVIEW
             11.1.10 ROMSONS
                        TABLE 124 ROMSONS: BUSINESS OVERVIEW
             11.1.11 PRODIMED
                        TABLE 125 PRODIMED: BUSINESS OVERVIEW
             11.1.12 COOK MEDICAL
                        TABLE 126 COOK MEDICAL: BUSINESS OVERVIEW
             11.1.13 ACCESS VASCULAR, INC.
                        TABLE 127 ACCESS VASCULAR, INC.: BUSINESS OVERVIEW
             11.1.14 MEDICAL COMPONENTS, INC.
                        TABLE 128 MEDICAL COMPONENTS, INC.: BUSINESS OVERVIEW
             11.1.15 VYGON
                        TABLE 129 VYGON: BUSINESS OVERVIEW
     11.2 OTHER COMPANIES 
             11.2.1 3M
             11.2.2 ARGON MEDICAL DEVICES
             11.2.3 GUANGDONG BAIHE MEDICAL TECHNOLOGY CO., LTD.
             11.2.4 PFM MEDICAL
             11.2.5 MEDI-TECH DEVICES PVT. LTD.
             11.2.6 MEDLINE INDUSTRIES, LP
             11.2.7 KIMAL
             11.2.8 DELTA MED
             11.2.9 NEWTECH MEDICAL DEVICES
             11.2.10 SHANGHAI PUYI MEDICAL INSTRUMENTS CO., LTD.
 
*Details on Business Overview, Products Offered, Recent Developments, MnM View, Right to win, Strategic choices made, Weaknesses and competitive threats might not be captured in case of unlisted companies. 
 
12 APPENDIX (Page No. - 186)
     12.1 DISCUSSION GUIDE 
     12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’  SUBSCRIPTION PORTAL 
     12.3 CUSTOMIZATION OPTIONS 
     12.4 RELATED REPORTS 
     12.5 AUTHOR DETAILS 

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.

Secondary Research

This research study involved the use of comprehensive secondary sources; directories and databases such as D&B, Bloomberg Business, and Factiva; and white papers, annual reports, and companies’ house documents. Secondary research was used to identify and collect information for this extensive, technical, market-oriented, and commercial study of the vascular access device market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, technology perspectives, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side and demand side are detailed below. Industry experts such as CEOs, presidents, vice presidents, directors, marketing directors, marketing managers, and related executives from various key companies and organizations in the vascular access device industry were interviewed to obtain and verify both the qualitative and quantitative aspects of this research study. A robust primary research methodology has been adopted to validate the contents of the report and fill in the gaps.

A breakdown of the primary respondents is provided below:

Vascular Access Device Market Size, and Share

*Others include sales managers, marketing managers, and product managers.

Note: Tiers are defined based on a company’s total revenue, as of 2022: Tier 1 = >USD 5 billion, Tier 2 = USD 1 billion to USD 5 billion, and Tier 3 = <USD 1 billion.

To know about the assumptions considered for the study, download the pdf brochure

COMPANY NAME

DESIGNATION

AngioDynamics,Inc.

Assistant Manager Sales

ICU Medical, Inc.

Assistant Project Manager

Terumo Corporation

Business Development Manager

Market Size Estimation

The market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (revenue share analysis) primary interviews, and top-down approach (assessment of Individual shares of each vascular access device type, application, and end-user segment).

Vascular Access Device Market Size: Bottom Up Approach

Vascular Access Device Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Vascular Access Device Market Size: Top Down Approach

Vascular Access Device Market Size, and Share

Data Triangulation

After arriving at the market size, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments & subsegments, data triangulation, and market breakdown procedures were employed, wherever applicable.

Market Definition

Vascular access device are used in the administration of medication, fluids, and nutrition as well as in diagnostic and testing. These devices enable the direct administration of drugs into the patient bloodstream, which assists rapid treatment.

Key Stakeholders

  • Senior Management
  • Vascular access device manufacturers and distributors
  • Operations Department
  • Research and consulting firms

Objectives of the Study

  • To define, describe, segment, and forecast the vascular access device market by type, application, end user, and region
  • To provide detailed information about the factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
  • To analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall vascular access device market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To estimate and forecast the size of the vascular access device market in four main regions (along with their respective key countries), namely, North America, Europe, the Asia Pacific, and Rest of the World.
  • To profile the key players and analyze their market shares and core competencies3
  • To track and analyze competitive developments such as product launches, agreements, partnership, and acquisitions in the global vascular access device market
  • To benchmark players within the vascular access device market using the competitive leadership mapping framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offering.

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:

Product Analysis

  • Product matrix, which gives a detailed comparison of the product portfolio of each company

Company Information

  • Detailed analysis and profiling of additional market players (up to five)
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization

Instant Answers with GPT - Ask Now!

Ask real questions. Get complete answers !
Report Code
MD 5434
Published ON
Jul, 2023
REQUEST FREE SAMPLE REPORT
Choose License Type
BUY NOW
Inquire Before Buying
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Vascular Access Device Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback